MarketCapExport financials
Newell Brands (NWL)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
Newell Brands Balance Sheet 2025-2007 | NWL
Brief balance sheet overview of Newell Brands
This overview follows the five latest available annual observations between 2021 and 2025.
The asset base decreased -24.9%, from $14.3 billion to $10.7 billion. Resources became smaller over the five periods.
Asset growth of -24.9% was close to the -17.7% change in liabilities, leaving the funding profile broadly stable.
Internal capital represents 22.3% of the balance sheet versus 29.1% five periods ago. The cushion is thin.
Net debt exceeds equity by 1.86x. The burden makes the balance sheet sensitive to earnings, rates and cash flow.
The cash share moved from 3.1% to 1.9%. A higher figure generally provides more room in an adverse scenario.
Retained earnings remain negative at -$3.2 billion. This may reflect past losses or substantial shareholder distributions, so earnings and buybacks provide important context.
Overall picture
Newell Brands 's balance sheet profile remains vulnerable. Lower liabilities and capital accumulation are the main routes to improvement.
Annual Balance Sheet Newell Brands
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
4.45 B | 4.42 B | 4.36 B | 4.59 B | 4.56 B | 4.25 B | 5.38 B | 6.52 B | 10.1 B | 11.3 B | 2.8 B | 2.28 B | 1.61 B | 1.73 B | 2.01 B | 2.09 B | 2.23 B | - | - |
Long Term Debt |
4.54 B | 4.51 B | 4.58 B | 4.76 B | 4.88 B | 5.14 B | 5.39 B | 6.7 B | 9.89 B | 11.3 B | 2.69 B | 2.08 B | 1.66 B | 1.71 B | 1.81 B | 2.06 B | 2.02 B | - | - |
Long Term Debt Current |
113 M | 110 M | 122 M | 121 M | 122 M | 129 M | 132 M | - | - | - | 5.9 M | 6.7 M | 800 K | 1.2 M | 264 M | 170 M | 493 M | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | 7.67 B | 9.11 B | 14.6 B | 18.2 B | 3.46 B | 2.94 B | 2.39 B | 2.65 B | 2.65 B | - | - | - | - |
Total Current Liabilities |
2.52 B | 2.44 B | 2.9 B | 3.08 B | 3.32 B | 3.62 B | 2.98 B | 3.33 B | 4.32 B | 4.29 B | 1.99 B | 1.89 B | 1.6 B | 1.57 B | 1.66 B | 1.67 B | 1.76 B | - | - |
Total Liabilities |
8.32 B | 8.25 B | 9.05 B | 9.74 B | 10.1 B | 10.8 B | 10.6 B | 12.4 B | 19 B | 22.5 B | 5.45 B | 4.83 B | 3.99 B | 4.22 B | 4.31 B | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | 180 M | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-3.23 B | -2.94 B | -2.73 B | -2.34 B | -2.54 B | -3.17 B | -2.4 B | -2.49 B | 4.61 B | 2.29 B | 2.09 B | 2.11 B | 2.24 B | 2.29 B | 2.1 B | 2.06 B | 1.82 B | - | - |
Total Assets |
10.7 B | 11 B | 12.2 B | 13.3 B | 14.3 B | 14.7 B | 15.6 B | 17.7 B | 33.1 B | 33.8 B | 7.28 B | 6.68 B | 6.07 B | 6.22 B | 6.16 B | 6.41 B | 6.42 B | - | - |
Cash and Cash Equivalents |
203 M | 198 M | 332 M | 287 M | 440 M | 1.02 B | 349 M | 496 M | 486 M | 588 M | 275 M | 199 M | 226 M | 184 M | 170 M | 140 M | 278 M | 275 M | 329 M |
Book Value |
2.39 B | 2.75 B | 3.11 B | 3.52 B | 4.16 B | 3.9 B | 5 B | 5.28 B | 14.2 B | 11.4 B | 1.83 B | 1.85 B | 2.08 B | 2 B | 1.85 B | 6.41 B | 6.42 B | - | - |
Total Shareholders Equity |
2.39 B | 2.75 B | 3.11 B | 3.52 B | 4.16 B | 3.92 B | 4.96 B | 5.24 B | 14.1 B | 11.3 B | 1.82 B | 1.85 B | 2.07 B | 2 B | 1.85 B | 1.9 B | 1.78 B | 1.59 B | 2.22 B |
Annual performance
Select metrics to display
All numbers in USD currency
Quarterly Balance Sheet Newell Brands
| 2026-Q2 | 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | 2010-Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
4.54 B | 4.54 B | 4.54 B | 4.54 B | 4.52 B | 4.09 B | 4.06 B | 4.56 B | 4.74 B | 4.75 B | 4.78 B | 4.76 B | 4.76 B | - | 4.88 B | 4.88 B | 4.88 B | 4.88 B | 5.14 B | 5.14 B | 5.14 B | 5.14 B | 5.14 B | 5.39 B | 5.39 B | 5.39 B | 5.39 B | 6.7 B | 6.7 B | 6.7 B | 6.7 B | 9.89 B | 9.89 B | 9.89 B | 9.89 B | 11.3 B | 11.3 B | 11.3 B | 11.3 B | 2.67 B | 2.67 B | 2.67 B | 2.67 B | 2.08 B | 2.08 B | 2.08 B | 2.08 B | 1.66 B | 1.66 B | 1.66 B | 1.66 B | 1.71 B | 1.71 B | 1.71 B | 1.71 B | 1.81 B | 1.81 B | 1.81 B | 1.81 B | 2.1 B | 2.05 B |
Total Liabilities |
8.61 B | 8.52 B | 8.59 B | 8.82 B | 8.59 B | 8.91 B | 8.97 B | 9.02 B | 9.45 B | 9.7 B | 9.94 B | 9.74 B | 10.9 B | - | 10.2 B | 10.1 B | 10.5 B | 10.6 B | 10.5 B | 10.8 B | 10.8 B | 10.8 B | 10.8 B | 10.6 B | 10.6 B | 10.6 B | 10.6 B | 12.5 B | 12.5 B | 12.5 B | 12.5 B | 19 B | 19 B | 19 B | 19 B | 22.5 B | 22.5 B | 22.5 B | 22.5 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 231 M | 180 M | 75.4 M | - | - | 188 M | 188 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-3.15 B | -3.26 B | -2.91 B | -2.93 B | -2.98 B | -2.89 B | -2.69 B | -2.74 B | -2.64 B | -2.42 B | -2.44 B | -2.34 B | -2.13 B | - | -2.37 B | -2.6 B | -2.7 B | -2.89 B | -3.08 B | -3.17 B | -3.17 B | -3.17 B | -3.17 B | -2.4 B | -2.4 B | -2.4 B | -2.4 B | -2.51 B | -2.51 B | -2.51 B | -2.51 B | 4.61 B | 4.61 B | 4.61 B | 4.61 B | 2.29 B | 2.29 B | 2.29 B | 2.29 B | 2.09 B | 2.09 B | 2.09 B | 2.09 B | 2.11 B | 2.11 B | 2.11 B | 2.11 B | 2.24 B | 2.24 B | 2.24 B | 2.24 B | 2.29 B | 2.29 B | 2.29 B | 2.29 B | 2.1 B | 2.1 B | 2.1 B | 2.1 B | 2 B | 1.98 B |
Total Assets |
11.1 B | 10.9 B | 11.3 B | 11.5 B | 11.3 B | 11.8 B | 12 B | 12.1 B | 12.6 B | 13 B | 13.3 B | 13.3 B | 14.7 B | - | 14.2 B | 14.2 B | 14.5 B | 14.6 B | 14.3 B | 14.7 B | 14.7 B | 14.7 B | 14.7 B | 15.6 B | 15.6 B | 15.6 B | 15.6 B | 17.7 B | 17.7 B | 17.7 B | 17.7 B | 33.1 B | 33.1 B | 33.1 B | 33.1 B | 33.8 B | 33.8 B | 33.8 B | 33.8 B | 7.26 B | 7.22 B | 7.26 B | 7.26 B | 6.56 B | 6.68 B | 6.68 B | 6.68 B | 6.07 B | 6.07 B | 6.07 B | 6.07 B | 6.22 B | 6.22 B | 6.22 B | 6.22 B | 6.16 B | 6.16 B | 6.16 B | 6.16 B | 6.57 B | 6.56 B |
Cash and Cash Equivalents |
209 M | 201 M | 229 M | 219 M | 233 M | 521 M | 405 M | 400 M | 422 M | 330 M | 285 M | 287 M | 661 M | 338 M | 379 M | 440 M | 517 M | 637 M | 682 M | 981 M | 981 M | 981 M | 981 M | 349 M | 349 M | 349 M | 349 M | 496 M | 496 M | 496 M | 496 M | 486 M | 486 M | 486 M | 486 M | 588 M | 588 M | 588 M | 588 M | 275 M | 275 M | 275 M | 275 M | 199 M | 199 M | 199 M | 199 M | 226 M | 226 M | 226 M | 226 M | 184 M | 184 M | 184 M | 184 M | 170 M | 170 M | 170 M | 170 M | 154 M | 260 M |
Book Value |
2.45 B | 2.34 B | 2.7 B | 2.69 B | 2.69 B | 2.86 B | 3.08 B | 3.08 B | 3.13 B | 3.32 B | 3.33 B | 3.52 B | 3.78 B | - | 3.98 B | 4.09 B | 4.06 B | 4.01 B | 3.86 B | 3.9 B | 3.9 B | 3.9 B | 3.9 B | 5 B | 5 B | 5 B | 5 B | 5.25 B | 5.25 B | 5.25 B | 5.25 B | 14.2 B | 14.2 B | 14.2 B | 14.2 B | 11.4 B | 11.4 B | 11.4 B | 11.4 B | 7.26 B | 7.22 B | 7.26 B | 7.26 B | 6.56 B | 6.68 B | 6.68 B | 6.68 B | 6.07 B | 6.07 B | 6.07 B | 6.07 B | 6.22 B | 6.22 B | 6.22 B | 6.22 B | 6.16 B | 6.16 B | 6.16 B | 6.16 B | 6.57 B | 6.56 B |
Total Shareholders Equity |
2.45 B | 2.34 B | 2.7 B | 2.69 B | 2.69 B | 2.86 B | 3.08 B | 3.08 B | 3.13 B | 3.32 B | 3.33 B | 3.52 B | 3.86 B | 4.02 B | 4.05 B | 4.09 B | 4.06 B | 3.99 B | 3.84 B | 3.87 B | 3.87 B | 3.87 B | 3.87 B | 4.96 B | 4.96 B | 4.96 B | 4.96 B | 5.22 B | 5.22 B | 5.22 B | 5.22 B | 14.1 B | 14.1 B | 14.1 B | 14.1 B | 11.3 B | 11.3 B | 11.3 B | 11.3 B | 1.82 B | 1.82 B | 1.82 B | 1.82 B | 1.85 B | 1.85 B | 1.85 B | 1.85 B | 2.07 B | 2.07 B | 2.07 B | 2.07 B | 2 B | 2 B | 2 B | 2 B | 1.85 B | 1.85 B | 1.85 B | 1.85 B | 1.87 B | 1.9 B |
Quarterly performance
Select metrics to display
All numbers in USD currency
Balance Sheet is a fundamental financial report of Newell Brands , providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.
For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.
Features of balance sheet analysis- Vertical and horizontal analysis
Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods. - Asset quality
It is important to evaluate not only the amount of assets but also their liquidity and realizability. - Accounting for off-balance sheet liabilities
Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.
Balance sheet of other industry stocks – Household products
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
 |
Coty
COTY
|
$ 3.05 | -5.13 % | $ 2.68 B |  USA |
 |
Dogness (International) Corporation
DOGZ
|
$ 0.77 | 5.11 % | $ 13.7 M |  China |
 |
e.l.f. Beauty
ELF
|
$ 113.78 | -0.84 % | $ 6.63 B | USA |
 |
Edgewell Personal Care Company
EPC
|
$ 26.98 | -4.39 % | $ 1.28 B | USA |
 |
Acme United Corporation
ACU
|
$ 63.2 | -0.6 % | $ 239 M | USA |
 |
Revlon
REV
|
- | -4.41 % | $ 212 M | USA |
 |
Mannatech, Incorporated
MTEX
|
$ 8.51 | 4.29 % | $ 16.2 M | USA |
 |
Colgate-Palmolive Company
CL
|
$ 93.4 | -1.21 % | $ 75.5 B | USA |
 |
Nature's Sunshine Products
NATR
|
$ 12.26 | -3.54 % | $ 221 M | USA |
 |
Nu Skin Enterprises
NUS
|
$ 4.76 | -4.51 % | $ 235 M | USA |
 |
Church & Dwight Co.
CHD
|
$ 105.0 | -0.91 % | $ 25.5 B | USA |
 |
The Procter & Gamble Company
PG
|
$ 156.84 | -1.61 % | $ 366 B | USA |
 |
The Estée Lauder Companies
EL
|
$ 103.66 | -2.32 % | $ 37.6 B | USA |
 |
United-Guardian
UG
|
$ 6.75 | -0.15 % | $ 31 M | USA |
 |
Unilever PLC
UL
|
$ 64.4 | -1.26 % | $ 141 B |  Britain |
 |
Hims & Hers Health
HIMS
|
$ 29.21 | -0.31 % | $ 6.57 B | USA |
 |
LifeVantage Corporation
LFVN
|
$ 5.95 | -0.34 % | $ 74.6 M | USA |
 |
Inter Parfums
IPAR
|
$ 113.2 | -2.33 % | $ 3.63 B | USA |
 |
Helen of Troy Limited
HELE
|
$ 28.38 | -3.54 % | $ 653 M |  Bermuda |
 |
Spectrum Brands Holdings
SPB
|
$ 78.96 | -0.7 % | $ 2.03 B | USA |
 |
The Clorox Company
CLX
|
$ 84.77 | -3.05 % | $ 10.5 B | USA |
 |
Kimberly-Clark Corporation
KMB
|
$ 106.64 | -1.56 % | $ 35.4 B | USA |
 |
Natura &Co Holding S.A.
NTCO
|
- | - | $ 9.02 B | - |
 |
USANA Health Sciences
USNA
|
$ 14.22 | -3.4 % | $ 264 M | USA |